(BPT) - The role of scientific innovation and genomic cancer testing in guiding the treatment journey:

Over the last sixty years, advancements in scientific research have driven an evolution in our perception of cancer and how it is treated. There has been a shift from a “one-size-fits-all” approach toward identifying the unique genetic makeup of each patient's tumor.

Precision oncology allows us to identify specific genomic alterations that drive the growth and spread of a tumor and inform treatment plans. Bayer is committed to playing an active role in the journey towards individualized care, by advocating for widespread access to and educating on high-quality genomic cancer testing, commonly referred to as biomarker testing.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.